Table 3.
Population studies of pancreatic endocrine tumors
| Author, year | Number of PET cases in the population | Annual incidence (all types) | Comments |
|---|---|---|---|
| Moldow, 1968(Moldow and Connelly 1968) | NR | < 1/100,000* | All cases in Connecticut, USA over a given period. PETs grouped with other rare tumors of the pancreas |
| Eriksson, 1989(Eriksson et al. 1989) | 84 | 0.4/100,000 | Well defined region in Sweden. Single referral hospital |
| Watson, 1989(Watson et al. 1989) | 94 | 0.23/100,000 | Well defined Northern Irish population. Same series as Buchanan et al.(Buchanan et al. 1986) |
| Carriaga, 1995(Carriaga and Henson 1995) | 402 | < 0.6/100,000* | SEER data 1973–1987. Exact incidence of PETs not provided. |
| Lam, 1997(Lam and Lo 1997) | 53 | 0.2/100,000 | Referral to a single hospital in Hong Kong |
| Lepage, 2004(Lepage et al. 2004) | 47 | ♀: 0.12/100,000 ♂: 0.19/100,000 |
Well defined geographic region in France |
| Halfdanarson, 2007(Halfdanarson et al. 2007) | 1488 | ♀: 0.2/100,000 ♂: 0.3/100,000 |
SEER data 1973–2000. All (neuro)endocrine tumors of the pancreas |
NR: Not reported, SEER: Surveillance, Epidemiology, and End Results
*
Accurate figure not provided for pancreatic endocrine tumors